Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Background Cardiac biomarkers and left ventricular hypertrophy (LVH) are related to the risk of stroke and death in patients with atrial fibrillation. We investigated the interrelationship between LVH and cardiac biomarkers and their independent associations with outcomes. Methods and Results Plasma...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Ziad Hijazi, Paolo Verdecchia, Jonas Oldgren, Ulrika Andersson, Gianpaolo Reboldi, Giuseppe Di Pasquale, Giovanni Mazzotta, Fabio Angeli, John W. Eikelboom, Michael D. Ezekowitz, Stuart J. Connolly, Salim Yusuf, Lars Wallentin
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Wiley 2019-01-01
Sraith:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Ábhair:
atrial fibrillation
biomarker
left ventricular hypertrophy
risk prediction
Rochtain ar líne:https://www.ahajournals.org/doi/10.1161/JAHA.118.010107

Ar líne

https://www.ahajournals.org/doi/10.1161/JAHA.118.010107

Míreanna comhchosúla